Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative GIK and postoperative NT-proBNP in CABG patients with ventricular dysfunction
IRCT201008223438N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of glucose, human insulin and Potassium in coronary arteriosclerosis and left ventricular systolic dysfunction (LVSD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative NT-proBNP level. Started Sep 2010; status: completed.
02
Drugs
glucosehuman insulinPotassium
03
Conditions
coronary arteriosclerosisleft ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on IRCT201008223438N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201008223438N1.